Safety and Tolerability of SHR-1918 in Healthy Subjects

NCT05432544 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipemia

Interventions

DRUG: SHR-1918
DRUG: SHR-1918 placebo

Sponsor

Beijing Suncadia Pharmaceuticals Co., Ltd